Cutler Group LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cutler Group LP

$307 Million
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$144.95 - $152.29 $1.13 Million - $1.19 Million	-7,800 Reduced 85.71%	1,300 $196,000
Q2 2022 Aug 04, 2022	BUY	$83.14 - $145.99 $348,855 - $612,574	4,196 Added 85.56%	9,100 $1.33 Million
Q1 2022 Apr 14, 2022	BUY	$110.08 - $142.92 $329,799 - $428,188	2,996 Added 157.02%	4,904 $581,000
Q4 2021 Jan 18, 2022	BUY	$99.73 - $148.48 $91,352 - $136,007	916 Added 92.34%	1,908 $262,000
Q3 2021 Oct 26, 2021	SELL	$98.85 - $138.91 $76,806 - $107,933	-777 Reduced 43.92%	992 $137,000
Q1 2021 Apr 26, 2021	SELL	$64.07 - $91.75 $252,628 - $361,770	-3,943 Reduced 69.03%	1,769 $120,000
Q4 2020 Jan 21, 2021	BUY	$65.07 - $98.24 $191,761 - $289,513	2,947 Added 106.58%	5,712 $489,000
Q3 2020 Oct 27, 2020	SELL	$59.04 - $77.95 $117,902 - $155,666	-1,997 Reduced 41.94%	2,765 $179,000
Q1 2020 May 07, 2020	SELL	$27.51 - $57.29 $106,986 - $222,800	-3,889 Reduced 44.95%	4,762 $162,000
Q4 2019 Feb 06, 2020	SELL	$40.86 - $57.65 $32,320 - $45,601	-791 Reduced 8.38%	8,651 $470,000
Q3 2019 Oct 28, 2019	SELL	$37.38 - $49.47 $219,943 - $291,081	-5,884 Reduced 38.39%	9,442 $393,000
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $589,926 - $993,490	14,826 Added 2965.2%	15,326 $671,000
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $17,260 - $26,645	500 New	500 $25,000
Q4 2018 Feb 05, 2019	SELL	$29.75 - $42.9 $2,975 - $4,290	-100 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$32.79 - $43.0 $6,558 - $8,600	-200 Reduced 66.67%	100 $3,000
Q2 2018 Aug 10, 2018	SELL	$23.62 - $42.29 $112,407 - $201,258	-4,759 Reduced 94.07%	300 $11,000
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $113,776 - $174,839	5,059 New	5,059 $130,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account